Dr. Hoàng Quốc Chính (Chinh Quoc Hoang) earned his PhD in Molecular Biology at New Mexico State University in 2010. He has worked as a researcher at UT Southwestern Medical Center, Indiana State University, King's College London, the Vietnam National Institute of Medicinal Materials and the Vinmec Institute of Stem Cell and Gene Technology, and has taught research methodology at university level. He has more than 17 publications in international journals.
Education
- PhD, Molecular Biology (developmental biology) — New Mexico State University, USA, 2010
- MS, Molecular Biology (virology) — New Mexico State University, USA, 2007. Graduate study funded by a Vietnamese government (Project 322) scholarship.
- BSc, Biology (microbiology) — VNU University of Science, Hanoi, 1999
Research and professional experience
| Years | Role and institution | Focus |
|---|---|---|
| 2025–present | Founder and director, Institute of Traditional Medicine Biochemistry (Viện Sinh Hóa Đông Y Dược), Hanoi | Formulation research on traditional herbal remedies for chronic metabolic and joint conditions in people |
| 2021–2024 | Principal investigator, Institute of Applied Technology (Viện Ứng dụng và Công nghệ), Ministry of Science and Technology, Vietnam | Molecular basis of strain degeneration and cordycepin biosynthesis in Cordyceps militaris; funded by the Vingroup Innovation Foundation (VINIF) |
| 2017–2021 | Project lead, Vinmec Institute of Stem Cell and Gene Technology | CAR-T cell manufacturing; hereditary cancer and targeted-therapy genetic testing services |
| 2016–2017 | Research fellow, King's College London, UK | Drug-target discovery for blood cancers |
| 2015–2016 | Researcher, National Institute of Medicinal Materials, Vietnam | Effects of a Crinum latifolium leaf extract on benign prostatic hyperplasia in an animal model |
| 2014–2015 | Researcher, Indiana State University, USA | Mechanisms of heart failure in mouse models |
| 2011–2014 | Postdoctoral researcher, UT Southwestern Medical Center, USA | Gene regulation in pancreatic acinar cells (PTF1A, NGN3); bioinformatics pipelines for sequencing data |
| 2006–2010 | Graduate researcher, New Mexico State University, USA | Genetic control of eye development in Drosophila |
Teaching: head of the basic sciences unit, Faculty of Laboratory Pharmacy, Dong Do University, Hanoi (research methodology; molecular pathology); teaching assistant in cell biology, New Mexico State University (2008–2009). Award: training award, Beta Cell Biology Consortium (2012).
Why this background matters for this site
Most claims about dog supplements rest on one of three kinds of evidence: laboratory mechanisms, animal-model experiments, or clinical trials in dogs. Dr. Hoàng has designed and run the first two kinds of study for most of his career — cell and molecular work, mouse genetic models, and an animal-model study of a plant extract — and has taught how studies should be designed and read. That experience is what the site's rating rules rely on: separating a plausible mechanism or a positive animal model from a between-group result in a controlled trial of dogs, and checking that a product actually contains the preparation that was studied.
What he reviews, and what he does not
- He set the evidence rating rules published in our methodology and reviews ratings against them.
- He reviews how studies are summarized: design, number of dogs, doses, outcomes, and whether results were between groups or only within a group.
- He reviews dose comparisons between product labels and study doses.
- He is not a veterinarian. His review is not veterinary clinical review, diagnosis or individual advice. Decisions about a dog's health belong with its veterinarian.
Disclosures
Dr. Hoàng founded and directs the Institute of Traditional Medicine Biochemistry, which develops herbal formulations for chronic conditions in people. The institute does not make or sell pet products, and he receives no payment from any pet supplement company. See About and our editorial policy.
Selected publications
- Hoang CQ, et al. Molecular mechanisms underlying phenotypic degeneration in Cordyceps militaris: insights from transcriptome reanalysis and osmotic stress studies. Scientific Reports. 2024.
- Azevedo-Pouly A, …, Hoang CQ, et al. Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation. PLoS One. 2023;18:e0291512.
- Hoang CQ, et al. Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma. Molecular and Clinical Oncology. 2021;15(3).
- Hoang CQ, et al. Transcriptional maintenance of pancreatic acinar identity, differentiation, and homeostasis by PTF1A. Molecular and Cellular Biology. 2016;36(24):3033–3047.
- Krah NM, …, Hoang CQ, et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. eLife. 2015;4:e07125.
Research described on this page shows the reviewer's scientific background. It is not evidence that any treatment or commercial product works.
To report an error in a rating or a newer study, use the contact form.